In reporting January quarter financial results, Dell said it has a $2.9 backlog of AI servers, up from just $800 million two quarters earlier, most of them powered by Nvidia H100 chips.

Dell has just unleashed its new PowerEdge XE9712 with NVIDIA GB200 NVL72 AI servers, with 30x faster real-time LLM performance over the H100 AI GPU. Dell Technologies' new AI Factory with NVIDIA ...

Dell’s commitment to looking across the broad spectrum of chips manufacturers from AMD and Intel to Nvidia and even chip startups comes during an explosion of innovation and massive market ...

New is the Dell AI Factory with Nvidia, which integrates Dell’s compute, storage, client device, and software capabilities with Nvidia’s AI infrastructure and software suite along with a high ...

If you’re looking for the best Dell laptop to power up your productivity, Black Friday is the perfect time to buy. Known for their versatility, performance, and sleek design, Dell laptops ...

If you’re seeking a new laptop, Dell laptops are a tried and true option for on-the-go work and play due to their strong performance and reliability. After reviewing dozens of different models ...

It features an NVIDIA GeForce RTX 4060 with 8GB of dedicated GDDR6 VRAM, 16GB of DDR5 RAM, and a solid Intel Core i7 processor at up to 4.90 GHz in Turbo. The screen of the Dell G16-7630 is ...

It combines Dell Technologies solutions and services optimized for AI workloads and supports an open ecosystem of partners comprising NVIDIA NVDA, Meta Platforms, Microsoft and Hugging Face.

One stock to keep an eye on is Novartis (NVS). NVS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 13.33. This compares to its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In trading on Wednesday, shares of Novartis (Symbol: NVS) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $109.755 per share. By comparison ...

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple ...